Synthetic studies on novel Syk inhibitors. Part 1: Synthesis and structure-activity relationships of pyrimidine-5-carboxamide derivatives (vol 13, pg 4936, 2005)

被引：2

作者：

Hisamichi, H

Naito, R

Toyoshima, A

Kawano, N

Ichikawa, A

Orita, A

Orita, M

Hamada, N

Takeuchi, M

Ohta, M

Tsukamoto, S

机构：

[1] Astellas Pharma Inc, Inst Drug Discovery Res, Tsukuba, Ibaraki 3058585, Japan

[2] Astellas Pharma Inc, Dept Clin Dev, Tokyo 1748612, Japan

来源：

BIOORGANIC & MEDICINAL CHEMISTRY | 2005年 / 13卷 / 22期

关键词：

D O I：

10.1016/j.bmc.2005.08.007

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

引用

页码：6277 / 6279

页数：3

共 50 条

[41] Design, synthesis, structure-activity relationships study and X-ray crystallography of 3-substituted-indolin-2-one-5-carboxamide derivatives as PAK4 inhibitors
Guo, Jing
Zhao, Fan
Yin, Wenbo
Zhu, Mingyue
Hao, Chenzhou
Pang, Yu
Wu, Tianxiao
Wang, Jian
Zhao, Dongmei
Li, Haitao
Cheng, Maosheng
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, 155 : 197 - 209
[42] Structure-activity relationships of 3-deoxy androgens as aromatase inhibitors. synthesis and biochemical studies of 4-substituted 4-ene and 5-ene steroids
Nagaoka, M
Watari, Y
Yajima, H
Tsukioka, K
Muroi, Y
Yamada, K
Numazawa, M
STEROIDS, 2003, 68 (06) : 533 - 542
[43] Design, synthesis, and structure-Activity relationship studies of novel tryptamine derivatives as 5-HT 1B receptor agonists
Fang, Liping
He, Shan
Yin, Peng
Wang, Ning
Zhang, Bin
Jin, Haixiao
JOURNAL OF MOLECULAR STRUCTURE, 2022, 1265
[44] Design, Synthesis, and Structure-Activity Relationship Study of Novel Indole-2-carboxamide Derivatives as Anti-inflammatory Agents for the Treatment of Sepsis (vol 59, pg 4637, 2016)
Liu, Zhiguo
Tang, Longguang
Zhu, Heping
Xu, Tingting
Qiu, Chenyu
Zheng, Suqing
Gu, Yugui
Feng, Jianpeng
Zhang, Yali
Liang, Guang
JOURNAL OF MEDICINAL CHEMISTRY, 2025, 68 (04) : 4988 - 4989
[45] Design, synthesis and structure-activity relationship studies of the biaryl 1-(2-naphthyl)-1H-pyrazole-5-carboxylamides as potent factor Xa inhibitors.
Jia, ZZJ
Wu, YH
Huang, WR
Goldman, E
Zhang, PL
Kanter, JP
Woolfrey, J
Wong, P
Huang, B
Sinha, U
Park, G
Reed, A
Scarborough, RM
Zhu, BY
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 223 : A92 - A92
[46] Peptidyl human heart chymase inhibitors.: Part 1:: Synthesis and inhibitory activity of difluoromethylene ketone derivatives bearing P′ binding subsites (vol 8, pg 913, 1998)
Eda, M
Ashimori, A
Akahoshi, F
Yoshimura, T
Inoue, Y
Fukaya, C
Nakajima, M
Fukuyama, H
Imada, T
Nakamura, N
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1998, 8 (13) : 1778 - 1778
[47] A novel Syk family kinase inhibitor:: Design, synthesis, and structure-activity relationship of 1,2,4-triazolo[4,3-c]pyrimidine and 1,2,4-triazolo[1,5-c]pyrimidine derivatives
Hirabayashi, Akihito
Mukaiyama, Harunobu
Kobayashi, Hiroaki
Shiohara, Hiroaki
Nakayama, Satoko
Ozawa, Motoyasu
Miyazawa, Keiji
Misawa, Keiko
Ohnota, Hideki
Isaji, Masayuki
BIOORGANIC & MEDICINAL CHEMISTRY, 2008, 16 (15) : 7347 - 7357
[48] Substituted 1, 3, 5-triazine derivatives as adenosine A2A receptor antagonists: Synthesis, structure-activity relationships and molecular modelling studies
Singh, Udaya
Bhat, Hans
MOVEMENT DISORDERS, 2014, 29 : S62 - S62
[49] Novel highly potent adenosine deaminase inhibitors containing the pyrazolo[3,4-d]pyrimidine ring system. Synthesis, structure-activity relationships and molecular modeling studies
Lavecchia, A
Da Settimo, F
Primofiore, G
La Motta, C
Taliani, S
Simorini, F
Marini, AM
Mugnaini, L
Novellino, E
Proceedings of the Joint Meeting on Medicinal Chemistry, 2005, : 99 - 103
[50] Novel, highly potent adenosine deaminase inhibitors containing the pyrazolo[3,4-d]pyrimidine ring system.: Synthesis, structure-activity relationships, and molecular modeling studies
Da Settimo, F
Primofiore, G
La Motta, C
Taliani, S
Simorini, F
Marini, AM
Mugnaini, L
Lavecchia, A
Novellino, E
Tuscano, D
Martini, C
JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (16) : 5162 - 5174

← 1 2 3 4 5 →